BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 27995542)

  • 1. Bone scan index of the jaw: a new approach for evaluating early-stage anti-resorptive agents-related osteonecrosis.
    Watanabe S; Nakajima K; Mizokami A; Yaegashi H; Noguchi N; Kawashiri S; Inokuchi M; Kinuya S
    Ann Nucl Med; 2017 Apr; 31(3):201-210. PubMed ID: 27995542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative bone scan imaging using BSI and BUV: an approach to evaluate ARONJ early.
    Yamamoto Y; Mitsunaga S; Horikawa A; Hino A; Kurihara H
    Ann Nucl Med; 2020 Jan; 34(1):74-79. PubMed ID: 31705367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative evaluation of anti-resorptive agent-related osteonecrosis of the jaw using bone single photon emission computed tomography in clinical settings: relationship between clinical stage and imaging.
    Okui T; Kobayashi Y; Tsujimoto M; Satoh K; Toyama H; Matsuo K
    Ann Nucl Med; 2020 Sep; 34(9):620-628. PubMed ID: 32557015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antiresorptive drugs on bony turnover in the jaw: denosumab compared with bisphosphonates.
    Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Kehl V; Jansen H; Hahnefeld L; Koerdt S; Otto S; Pautke C
    Br J Oral Maxillofac Surg; 2014 Apr; 52(4):308-13. PubMed ID: 24582013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between Systemic Markers of Bone Turnover or Bone Mineral Density and Anti-Resorptive Agent-Related Osteonecrosis of the Jaw in Patients Treated with Anti-Resorptive Agents.
    Tohashi K; Nakabayashi M; Kodani I; Kidani K; Ryoke K
    Yonago Acta Med; 2016 Mar; 59(1):45-53. PubMed ID: 27046950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone scintigraphy and SPECT/CT of bisphosphonate-induced osteonecrosis of the jaw.
    Dore F; Filippi L; Biasotto M; Chiandussi S; Cavalli F; Di Lenarda R
    J Nucl Med; 2009 Jan; 50(1):30-5. PubMed ID: 19091894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
    O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is bone turnover of jawbone and its possible over suppression by bisphosphonates of etiologic importance in pathogenesis of bisphosphonate-related osteonecrosis?
    Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Kehl V; Jansen H; Hahnefeld L; Otto S; Pautke C
    J Oral Maxillofac Surg; 2014 May; 72(5):903-10. PubMed ID: 24485975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of bone scans in advanced prostate carcinoma using fully automated and semi-automated bone scan index methods.
    Takahashi Y; Yoshimura M; Suzuki K; Hashimoto T; Hirose H; Uchida K; Inoue S; Koizumi K; Tokuuye K
    Ann Nucl Med; 2012 Aug; 26(7):586-93. PubMed ID: 22744807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring indices of bone inflammatory activity of the jaw using SPECT bone scintigraphy: a study of ARONJ patients.
    Hata H; Kitao T; Sato J; Asaka T; Ohga N; Imamachi K; Hirata K; Shiga T; Yamazaki Y; Kitagawa Y
    Sci Rep; 2020 Jul; 10(1):11385. PubMed ID: 32647190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases.
    Wakabayashi H; Nakajima K; Mizokami A; Namiki M; Inaki A; Taki J; Kinuya S
    Ann Nucl Med; 2013 Nov; 27(9):802-7. PubMed ID: 23828554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-center analysis of antiresorptive agent-related osteonecrosis of the jaw in lung cancer patients.
    Okamura M; Fujita K; Yamamoto Y; Kanai O; Nakatani K; Horimoto K; Hashimoto M; Sawai S; Shimosato M; Yoshida K; Mio T
    Asia Pac J Clin Oncol; 2020 Dec; 16(6):380-384. PubMed ID: 32893984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging findings of bisphosphonate-related osteonecrosis of the jaw with emphasis on early magnetic resonance imaging findings.
    Krishnan A; Arslanoglu A; Yildirm N; Silbergleit R; Aygun N
    J Comput Assist Tomogr; 2009; 33(2):298-304. PubMed ID: 19346864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major histocompatibility complex class II polymorphisms are associated with the development of anti-resorptive agent-induced osteonecrosis of the jaw.
    Stockmann P; Nkenke E; Englbrecht M; Schlittenbauer T; Wehrhan F; Rauh C; Beckmann MW; Fasching PA; Kreusch T; Mackensen A; Wullich B; Schett G; Spriewald BM
    J Craniomaxillofac Surg; 2013 Jan; 41(1):71-5. PubMed ID: 23218978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of bone scintigraphy in the assessment of mandibular metabolism during long-term bisphosphonate administration.
    Ohbayashi Y; Nakai F; Iwasaki A; Ogawa T; Yamamoto Y; Nishiyama Y; Miyake M
    Odontology; 2017 Jul; 105(3):382-390. PubMed ID: 27770302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary report about treatment of bisphosphonate related osteonecrosis of the jaw with Er:YAG laser ablation.
    Stübinger S; Dissmann JP; Pinho NC; Saldamli B; Seitz O; Sader R
    Lasers Surg Med; 2009 Jan; 41(1):26-30. PubMed ID: 19143020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and Risk of Anti-Resorptive Agent-Related Osteonecrosis of the Jaw after Tooth Extraction: A Retrospective Study.
    Shimizu R; Sukegawa S; Sukegawa Y; Hasegawa K; Ono S; Nakamura T; Fujimura A; Fujisawa A; Nakano K; Takabatake K; Kawai H; Nagatsuka H; Furuki Y
    Healthcare (Basel); 2022 Jul; 10(7):. PubMed ID: 35885858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and risk of antiresorptive agent-related osteonecrosis of the jaw (ARONJ) after tooth extraction in patients with autoimmune disease.
    Fujieda Y; Doi M; Asaka T; Ota M; Hisada R; Ohnishi N; Kono M; Kameda H; Nakazawa D; Kato M; Amengual O; Takahata M; Yasuda S; Kitagawa Y; Atsumi T
    J Bone Miner Metab; 2020 Jul; 38(4):581-588. PubMed ID: 32076874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiresorptive agent-related osteonecrosis of the jaw in prostate cancer patients with bone metastasis treated with bone-modifying agents.
    Nakai Y; Kanaki T; Yamamoto A; Tanaka R; Yamamoto Y; Nagahara A; Nakayama M; Kakimoto KI; Ishibashi M; Nishimura K
    J Bone Miner Metab; 2021 Mar; 39(2):295-301. PubMed ID: 32886176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of bone scan index change over time on automated calculation in bone scintigraphy.
    Shintawati R; Achmad A; Higuchi T; Shimada H; Hirasawa H; Arisaka Y; Takahashi A; Nakajima T; Tsushima Y
    Ann Nucl Med; 2015 Dec; 29(10):911-20. PubMed ID: 26373556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.